Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 11 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 16 hours agoA potential approval will also show that Moderna isn't just a one-product company and instead can build a billion-dollar respiratory vaccine portfolio,...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 6 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 5 days agoThe FDA has informed Moderna that it is working to conclude...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 4 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 7 days agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the ...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...